India covid-19 experts vaccine India

Covid-19 vaccine for children: A look at other options besides Covaxin

Reading now: 908
www.livemint.com

Covaxin, for the beneficiaries aged between 2-18 years, worried parents can now heave a sigh of relief. However, the final approval is yet to be given, which will be done by the Drugs Controller General of India (DCGI).

Experts said vaccination for children against Covid-19 was more necessary than ever as schools have reopened in many states.

Bharat Biotech's Covaxin for children is one of the first worldwide approval for COVID-19 vaccines for the age group of beneficiaries belonging to 2-18 years.

Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for Covaxin (BBV152) to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) and have provided their positive

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA